| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |